Claris Lifesciences to sell 20% stake in JV Otsuka Pharmaceutical India

For USD 20 million

Claris Lifesciences announced that it has entered a definitive agreement with Otsuka Pharmaceutical Factory, Inc. (Japan) to sell its 20% stake in joint venture; Otsuka Pharmaceutical India (formerly known as Claris Otsuka), for a total consideration of USD 20 million.

The closure of the transaction is subject to regulatory approvals, including FIPB, after this CLL will not have any stake in Otsuka Pharmaceutical India.

Powered by Capital Market - Live News